Drug intelligence / Profile preview

strontium-82 chloride

Development stage
Unknown
Lead developer
BWXT Medical
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Strontium-82 chloride is a radioisotope and positron emission tomography (PET) imaging generator active pharmaceutical ingredient (API). It serves as the parent radionuclide loaded into rubidium-82 (Rb-82) generators, such as CardioGen-82 and Ruby-Fill, which produce rubidium chloride Rb-82 injection. In the generator, strontium-82 decays to rubidium-82, which is then eluted and administered to patients for myocardial perfusion imaging. This diagnostic radiopharmaceutical is indicated for the evaluation of suspected or existing coronary artery disease. Strontium-82 chloride is manufactured by BWXT Medical (which acquired Nordion's medical isotope business in 2018) and other suppliers.

Other names
Sr-82Sr82Sr 82strontium [82Sr] chloridestrontium [82Sr] dichloridestrontium-82strontium82strontium 82strontium-82 chloride radiochemical solutionstrontium82 chloride radiochemical solutionstrontium 82 chloride radiochemical solution

Beyond the preview

Go deeper on strontium-82 chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on strontium-82 chloride.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call